November 18, 2015
The dispensing rate of generic medicines will increase from 88% to as high as 92% by 2020, the IMS Institute for Healthcare Informatics reported
 
November 16, 2015

The drug is meant to be used on-demand to control bleeding episodes and as a way to reduce their frequency.

November 13, 2015
The drug was granted Fast Track, Breakthrough, Priority Review and Accelerated Approval status by the FDA and has shown an objective response rate of 59% with a median duration of about 12.4 months. 
November 13, 2015

Perrigo’s shareholders did not tender a majority of the company’s shares to Mylan by 8 a.m. EST Friday, effectively ending Mylan’s acquisition attempt. 

November 13, 2015

AtlanticLIVE’s event, “The Diabetes Divide,” addressed an issue that affects an estimated 415 million people worldwide. 

November 11, 2015

A new drug has been approved that, in conjunction with vemurafenib, is meant to treat metastatic melanoma that can't be removed through surgery with a certain gene mutation. 

November 11, 2015

As 2015 draws to a close, the year is on track to be one in which the value of the branded drugs losing their patent protection approaches an all-time high. The dozens of drugs that will have lost their patent protection this year are estimated to have global sales of $44 billion a year — the highest total since $53 billion worth of medications went off patent in 2012.

November 9, 2015

GlaxoSmithKline is celebrating 300 years. Originating as a small pharmacy in East London in 1715, GlaxoSmithKline has grown into the sixth largest global pharmaceutical company, the International Business Times reported Monday. "I'm extremely proud of all the history we have behind us," noted Nikki Yakes, GSK UK Pharma general manager. "It is a quite remarkable achievement to be able to trace our roots back to one young entrepreneur in 1715." (International Business Times)

November 6, 2015

Based on the company’s presentation accompanying a conference call on the acquisition, AstraZeneca’s focus to be on the treatment ZS Pharma is developing for hyperkalemia, a side effect of chronic kidney disease,

November 6, 2015

The two companies on Friday announced a development and commercialization deal for sotagliflozin, which is currently in development and undergoing Phase 3 trials. 

November 5, 2015

Genvoya can be used in adults and children 12 years of age and older who haven’t taken an HIV therapy before, and HIV-positive adults whose virus is suppressed. 

November 5, 2015

The change makes patients who earn up to four times the federal poverty level based on family size (up to $97,000 for a family of four) eligible for some of the 40 medicines offered for free by the program. 

November 4, 2015

The New York Times reported Tuesday that embattled drug maker Turing Pharmaceuticals, which made headlines when it acquired Daraprim and raised the price by more than 5,000% overnight, had announced a planned drop in price by the end of 2015. The Times pointed out that the 10% decrease. “Since acquiring Daraprim three months ago, our top priority has been to ensure that patients who need Daraprim have ready, affordable access to it,” Turing said in a letter. (New York Times)

November 3, 2015

With the completion of this step all Mylan needs is word from Perrigo’s shareholders on whether or not they will accept the company’s $27 billion acquisition offer, which was tendered on Sept. 14. 

November 3, 2015

Thinfilm’s NFC OpenSense tags are thin labels that can tell whether the injector has been used or not, and can send information about the injector’s state to a smartphone

November 2, 2015

The New York Times is reporting that Irish pharmaceutical company Shire has entered into an agreement to purchase Dyax, a biotechnology company that makes treatements for hereditary angioedema (HAE), for as much as $6.5 billion. “This highly complementary transaction aligns with and accelerates our strategy to build a global leading biotechnology company focused on rare diseases and specialty conditions,” Shire’s CEO Dr. Flemming Ornskov said. “It adds to our portfolio of best-in-class therapies addressing unmet needs in our core therapeutic areas, expanding and extending our leadership position in HAE.” (New York Times)

October 30, 2015

A new maintenance treatment for COPD from Novartis has been approved by the FDA. 

October 30, 2015

Patients prescribed Auvi-Q should contact their doctor for a prescription for a new epinephrine auto-injector, Sanofi’s chief medical officer said, and they should also call 877-319-8963 or 866-726-6340 for information about returning the auto-injector and a reimbursement, if needed

October 30, 2015

Perrigo’s motion for an injunction against Mylan’s proposed acquisition was not granted in New York’s Southern District Court. 

October 29, 2015

The company would not comment on th

October 29, 2015

Forbes is reporting that CVS and Express Scripts have cut ties with Valeant Pharmaceuticals’ specialty pharmacy Philidor Rx amid investigations into the company’s business practices. “In accordance with CVS/caremark’s standard auditing protocols, over the last several weeks we have been monitoring and reviewing the results of recent audits of Philidor’s practices,” CVS said in a statement. ”Based on the findings from those activities, we have terminated Philidor for noncompliance with the terms of its provider agreement.” (Forbes)

October 29, 2015

McKesson's North America pharmaceutical distribution and services revenues were $40.6 billion for the quarter, up 16% on a reported basis and 17% on a constant currency basis. 

October 28, 2015

The drug, which gained FDA approval in July, is indicated to treat papules and pustules associated with rosacea. 

October 28, 2015

Amgen announced Wednesday that it had received approval from the Food and Drug Administration for Imlygic (talimogene laherparepvec) for injection.